Show simple item record

Marked improvements in glycaemic outcomes following insulin pump therapy initiation in people with type 1 diabetes : a nationwide observational study in Scotland

dc.contributor.authorJeyam, Anita
dc.contributor.authorGibb, Fraser W
dc.contributor.authorMcKnight, John A
dc.contributor.authorKennon, Brian
dc.contributor.authorO'Reilly, Joseph E
dc.contributor.authorCaparrotta, Thomas M
dc.contributor.authorHöhn, Andreas
dc.contributor.authorMcGurnaghan, Stuart J
dc.contributor.authorBlackbourn, Luke A K
dc.contributor.authorHatam, Sara
dc.contributor.authorMcCrimmon, Rory J
dc.contributor.authorLeese, Graham
dc.contributor.authorLindsay, Robert S
dc.contributor.authorPetrie, John
dc.contributor.authorChalmers, John
dc.contributor.authorPhilip, Sam
dc.contributor.authorWild, Sarah H
dc.contributor.authorSattar, Naveed
dc.contributor.authorMcKeigue, Paul M
dc.contributor.authorColhoun, Helen M
dc.contributor.authorScottish Diabetes Research Network (SDRN) Epidemiology group
dc.date.accessioned2021-12-21T20:30:01Z
dc.date.available2021-12-21T20:30:01Z
dc.date.issued2021-06-01
dc.identifier.citationJeyam , A , Gibb , F W , McKnight , J A , Kennon , B , O'Reilly , J E , Caparrotta , T M , Höhn , A , McGurnaghan , S J , Blackbourn , L A K , Hatam , S , McCrimmon , R J , Leese , G , Lindsay , R S , Petrie , J , Chalmers , J , Philip , S , Wild , S H , Sattar , N , McKeigue , P M , Colhoun , H M & Scottish Diabetes Research Network (SDRN) Epidemiology group 2021 , ' Marked improvements in glycaemic outcomes following insulin pump therapy initiation in people with type 1 diabetes : a nationwide observational study in Scotland ' , Diabetologia , vol. 64 , no. 6 , pp. 1320-1331 . https://doi.org/10.1007/s00125-021-05413-7en
dc.identifier.issn0012-186X
dc.identifier.otherPURE: 199248368
dc.identifier.otherPURE UUID: 1c7409d4-864f-4a04-ab19-1db9d6309ba0
dc.identifier.otherPubMed: 33686483
dc.identifier.otherPubMedCentral: PMC8099793
dc.identifier.otherScopus: 85102314413
dc.identifier.otherWOS: 000626420500001
dc.identifier.otherORCID: /0000-0001-6164-211X/work/105177160
dc.identifier.urihttps://hdl.handle.net/2164/17733
dc.descriptionAcknowledgements We thank the SDRN Epidemiology Group: J. Chalmers (Diabetes Centre, Victoria Hospital, Kirkcaldy, UK), C. Fischbacher (Information Services Division, NHS National Services Scotland, Edinburgh, UK), B. Kennon (Queen Elizabeth University Hospital, Glasgow, UK), G. Leese (Ninewells Hospital, Dundee, UK), R. Lindsay (British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK), J. McKnight (Western General Hospital, NHS Lothian, Edinburgh, UK), J. Petrie (Institute of Cardiovascular & Medical Sciences, University of Glasgow, Glasgow, UK), R. McCrimmon (Division of Molecular and Clinical Medicine, University of Dundee, Dundee, UK), S. Philip (Grampian Diabetes Research Unit, Diabetes Centre, Aberdeen Royal Infirmary, Aberdeen, UK), D. McAllister (Institute of Health & Wellbeing, University of Glasgow, Glasgow, UK), E. Pearson (Population Health and Genomics, School of Medicine, University of Dundee, Dundee, UK) and S. Wild (Usher Institute, University of Edinburgh, Edinburgh, UK). Some of the data were presented as an abstract (poster presentation) at the 56th EASD Annual Meeting in 2020. Funding This study was supported by funding from Diabetes UK (17/0005627) and the Chief Scientist Office (ref. ETM/47).en
dc.format.extent12
dc.language.isoeng
dc.relation.ispartofDiabetologiaen
dc.rightsThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.en
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectDiabetes mellitus type 1en
dc.subjectHbA1cen
dc.subjectHypoglycaemiaen
dc.subjectInsulin pumpen
dc.subjectKetoacidosisen
dc.subjectR Medicineen
dc.subjectChief Scientist Office (CSO)en
dc.subjectETM/47en
dc.subjectOtheren
dc.subjectDiabetes UK (17/0005627)en
dc.subjectSupplementary Informationen
dc.subject.lccRen
dc.titleMarked improvements in glycaemic outcomes following insulin pump therapy initiation in people with type 1 diabetes : a nationwide observational study in Scotlanden
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Centre for Health Data Scienceen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Data Safe Havenen
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.1007/s00125-021-05413-7
dc.identifier.vol64en
dc.identifier.iss6en


Files in this item

Thumbnail
Name:
Jeyam_etal_Marked_improvements ...
Size:
978.6Kb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record